BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3326562)

  • 1. Effects of membrane structure on removal of low molecular weight proteins.
    Takesawa S; Ohashi H; Hidai H; Sakai K
    Artif Organs; 1987 Dec; 11(6):495-7. PubMed ID: 3326562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in beta 2-microglobulin removal between cellulosic and synthetic polymer membrane dialyzers.
    Mineshima M; Hoshino T; Era K; Kitano Y; Suzuki T; Sanaka T; Teraoka S; Agishi T; Ota K
    ASAIO Trans; 1990; 36(3):M643-6. PubMed ID: 2252773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new polymethylmethacrylate membrane for hemodialysis.
    Bonomini M; Fiederling B; Bucciarelli T; Manfrini V; Di Ilio C; Albertazzi A
    Int J Artif Organs; 1996 Apr; 19(4):232-9. PubMed ID: 8786174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
    Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
    Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and permeability of dialysis membranes sterilized by various methods.
    Sakai K
    J Biomater Appl; 1989 Oct; 4(2):71-101. PubMed ID: 2795440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of a new high-flux cellulose acetate membrane.
    Schaefer RM; Huber L; Gilge U; Bausewein K; Vienken J; Heidland A
    Int J Artif Organs; 1989 Feb; 12(2):85-90. PubMed ID: 2651325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialyzer permeability for low-molecular-weight proteins. Comparison between polysulfone, polyamide and cuprammonium-rayon dialyzers.
    Nensel U; Röckel A; Hillenbrand T; Bartel J
    Blood Purif; 1994; 12(2):128-34. PubMed ID: 7530014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of beta-2-microglobulin by diffusion alone is feasible using highly permeable dialysis membranes.
    Naitoh A; Tatsuguchi T; Okada M; Ohmura T; Sakai K
    ASAIO Trans; 1988; 34(3):630-4. PubMed ID: 3058183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative and qualitative assessment and clinical meaning of molecules removed with BK membranes.
    Buoncristiani U; Galli F; Benedetti S; Errico R; Beninati S; Ghibelli L; Floridi A; Canestrari F
    Contrib Nephrol; 1999; 125():133-58. PubMed ID: 9895437
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta 2-microglobulin removal by synthetic dialysis membranes. Mechanisms and kinetics of the molecule.
    Ronco C; Heifetz A; Fox K; Curtin C; Brendolan A; Gastaldon F; Crepaldi C; Fortunato A; Pietribasi G; Caberlotto A; Brunello A; Milan Manani S; Zanella M; La Greca G
    Int J Artif Organs; 1997 Mar; 20(3):136-43. PubMed ID: 9151148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations.
    Lornoy W; Becaus I; Billiouw JM; Sierens L; Van Malderen P; D'Haenens P
    Nephrol Dial Transplant; 2000; 15 Suppl 1():49-54. PubMed ID: 10737167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatibility of a new high-permeability modified cellulose membrane for haemodialysis.
    Ward RA; Schaefer RM; Falkenhagen D; Joshua MS; Heidland A; Klinkmann H; Gurland HJ
    Nephrol Dial Transplant; 1993; 8(1):47-53. PubMed ID: 8381935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of dialyzers used in shortened dialysis.
    Petersen J; Ramsey KD; Kang MS; Yeh IT
    ASAIO Trans; 1989; 35(3):338-40. PubMed ID: 2688714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo clearance and elimination of nine marker substances during hemofiltration with different membranes.
    Krämer BK; Pickert A; Hohmann C; Liebich HM; Müller GA; Hablitzel M; Risler T
    Int J Artif Organs; 1992 Jul; 15(7):408-12. PubMed ID: 1516991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyethersulfone as a high-performance membrane.
    Krieter DH; Lemke HD
    Contrib Nephrol; 2011; 173():130-136. PubMed ID: 21865785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of the serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis.
    Kabanda A; Jadoul M; Pochet JM; Lauwerys R; van Ypersele de Strihou C; Bernard A
    Kidney Int; 1994 Jun; 45(6):1689-96. PubMed ID: 7933817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of serum beta-2 microglobulin using high-performance membranes and analysis of changes in serum BMG levels after dialysis.
    Yasuhiro I; Eiichi N; Mineo O; Muneto Y; Toshihiro I; Masahiro F; Yoshifumi N; Masahito M; Ryuichi M
    Am J Nephrol; 1998; 18(3):228-32. PubMed ID: 9627039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-efficiency dialysis with PMMA dialyzers: treatment dose delivery and long-term results.
    David S; Cambi V
    Contrib Nephrol; 1999; 125():96-110. PubMed ID: 9895434
    [No Abstract]   [Full Text] [Related]  

  • 19. High-flux synthetic versus cellulosic membranes for beta 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration.
    Floege J; Granolleras C; Deschodt G; Heck M; Baudin G; Branger B; Tournier O; Reinhard B; Eisenbach GM; Smeby LC
    Nephrol Dial Transplant; 1989; 4(7):653-7. PubMed ID: 2510064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of 3 high-permeability dialysers].
    Montagnac R; Schillinger F; Milcent T; Cheriot J; Dupoirieux J; Turret MM; Manceaux JC
    Nephrologie; 1987; 8(5):257-9. PubMed ID: 3328103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.